StockNews.com upgraded shares of Koninklijke Philips (NYSE:PHG - Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday.
Several other equities analysts have also recently issued reports on PHG. BNP Paribas raised Koninklijke Philips from a "neutral" rating to an "outperform" rating in a research note on Tuesday, February 25th. UBS Group raised shares of Koninklijke Philips from a "neutral" rating to a "buy" rating in a research note on Thursday, February 20th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy".
Read Our Latest Stock Report on Koninklijke Philips
Koninklijke Philips Price Performance
NYSE PHG traded up $0.51 on Friday, reaching $27.58. 860,493 shares of the company's stock traded hands, compared to its average volume of 877,302. Koninklijke Philips has a 12 month low of $19.10 and a 12 month high of $32.91. The stock has a market cap of $25.93 billion, a PE ratio of -32.84, a P/E/G ratio of 0.82 and a beta of 0.78. The stock has a 50-day simple moving average of $26.51 and a 200 day simple moving average of $27.98. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.23 and a quick ratio of 0.74.
Koninklijke Philips (NYSE:PHG - Get Free Report) last posted its quarterly earnings results on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.01). Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. The company had revenue of $5.38 billion for the quarter, compared to the consensus estimate of $5.10 billion. As a group, research analysts predict that Koninklijke Philips will post 1.63 earnings per share for the current year.
Koninklijke Philips Cuts Dividend
The firm also recently declared an annual dividend, which will be paid on Friday, June 6th. Stockholders of record on Tuesday, May 13th will be paid a $0.886 dividend. This represents a dividend yield of 2.9%. The ex-dividend date is Tuesday, May 13th. Koninklijke Philips's dividend payout ratio is currently -89.29%.
Institutional Trading of Koninklijke Philips
A number of institutional investors have recently made changes to their positions in the stock. Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of Koninklijke Philips by 87.7% in the 4th quarter. Connor Clark & Lunn Investment Management Ltd. now owns 2,222,192 shares of the technology company's stock worth $56,266,000 after purchasing an additional 1,038,321 shares during the period. Bank of Montreal Can boosted its stake in Koninklijke Philips by 2,883.5% in the 3rd quarter. Bank of Montreal Can now owns 982,199 shares of the technology company's stock worth $32,157,000 after purchasing an additional 949,278 shares during the period. IHT Wealth Management LLC purchased a new position in Koninklijke Philips during the third quarter valued at $19,593,000. Northern Trust Corp grew its position in shares of Koninklijke Philips by 36.6% during the fourth quarter. Northern Trust Corp now owns 1,608,749 shares of the technology company's stock valued at $40,734,000 after purchasing an additional 430,757 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new position in Koninklijke Philips during the 4th quarter valued at approximately $10,655,000. Hedge funds and other institutional investors own 13.67% of the company's stock.
About Koninklijke Philips
(
Get Free Report)
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Recommended Stories
Before you consider Koninklijke Philips, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.
While Koninklijke Philips currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
